AbbVie announced its participation in the Bank of America Securities Healthcare Conference, scheduled for May 14, 2025. The company will engage in a fireside chat at 12:00 p.m. Central time.
The presentation will be available through a live audio webcast on AbbVie's Investor Relations website. An archived version of the session will also be accessible later that day.
"AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow," according to the company. AbbVie focuses on several therapeutic areas, including immunology, oncology, neuroscience, eye care, and Allergan Aesthetics products and services.
For more information about AbbVie, visit www.abbvie.com or follow them on social media platforms such as LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media inquiries can be directed to Gabby Tarbert at (224) 244-0111 or gabrielle.tarbert@abbvie.com. Investors may contact Liz Shea at (847) 935-2211 or liz.shea@abbvie.com.